News - MedTech & Diagnostics
Grattan report ‘pea and thimble’ trick for private health insurance

The latest proposals from the Grattan Institute suggesting changes to community rating for private health insurance amount to no more than a complex “pea and thimble” trick that on the authors own admission, will result in older Australian’s paying more for their health insurance.
The newly released: ‘Saving private health 2: Making private health insurance viable’ claims to offer solutions to save private health insurance, but would actually do damage, says Australian Private Hospitals Association (APHA) CEO Michael Roff.
“By allowing health insurers to risk rate insurance for those under 55, anyone in this age group who has a chronic health condition, has previously had surgery or who has a history of mental health issues would effectively be priced out of the private insurance market, throwing even more demand on the overburdened public hospital system.
“The proposals rely on illusory savings from the report released last week, when the report authors calculated billions of dollars of savings based on reducing bed days for private patients – ignoring the fact the overwhelmingly private hospitals are paid per episode, not per day.
You may also like Novel Australian labs to revolutionise STEMM innovation.
“This report merely compounds the errors and misunderstandings of the private health sector the authors were so keen to talk about last week.
Mr Roff said there is, however, room for improvement in the current system.
“We have a set of policy measures for private health insurance (the private health insurance rebate, lifetime health cover and the medicare levy surcharge) that have been effective over time, but are now 20 years old. The Australian health system as a whole would benefit from some sensible adjustments to these policies to ensure they are relevant in today’s environment.
“The Grattan Institute’s complex and convoluted proposals would damage both the public and private health systems,” he said.
Register FREE to receive the latest news, innovations and insights from Health Industry Hub; the only one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.
News - Pharmaceuticals

Opposition and Independents turn up the heat on HTA Review delays
Pressure is intensifying on the Federal Government to move from consultation to implementation on Health Technology Assessment (HTA) reforms. With […]
MoreNews - Pharmaceuticals

Boehringer Ingelheim tops pharma reputation rankings in ANZ, with Sanofi and Pfizer in close pursuit
Boehringer Ingelheim has secured the top spot for overall corporate reputation in Australia and New Zealand, according to PatientView’s latest […]
MoreNews - Pharmaceuticals

Ophthalmologists look to technology to bridge gaps in vision impairment: Roche report
The Asia-Pacific region, home to just over half of the world’s population, shoulders a disproportionate burden of vision loss – […]
MoreMedical and Science

Tinkering at the edges of reform won’t cut it: National Health and Medical Research Strategy
Australia’s health and medical research community has welcomed the release of the draft National Health and Medical Research Strategy, with […]
More